Skip to main content
Caplight Logo









Sonomind

Sonomind

Private
ParisHealthcare & Life Scienceshttps://www.sonomind.com/

Last Round

Series A

May 13, 2026

Total Funding Raised

$27.03M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Sonomind is a medical device company that develops non-invasive, personalized neuromodulation technology using low-intensity focused ultrasound to treat depression and other neuropsychiatric disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, 3D Printing, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

ultrasound neuromodulationbrain stimulationtreatment-resistant depressionnon-invasive brain stimulationfocused ultrasoundneuromodulationacoustic meta-lensesbrain mappingmedical devicedeep brain stimulationbioelectronic medicinepsychiatric technology3D-printed medical devicesneurotechbrain-computer interface

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sonomind Comparables

Compare Sonomind with similar companies based on industry and business-model similarity.

Sonomind comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SPIRE Therapeutics, Inc.
83%
Neurosona
81%
Zhongke Green Valley (Shenzhen) Medical Technology Co., Ltd.
78%

Sonomind Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 13, 2026
SeedSep 24, 2025

Key People

Founding team and executive leadership

Jeremy Bercoff

Chief Executive Officer

Executive Team

Sonomind Investors

Notable investors and investment history

Sonomind investors
InvestorRounds
Critical Path VenturesSeed, Series A
BpifranceSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 29, 2026

    Grew 31% QoQ, from 13 to 17 employees.

  • Jul 17, 2026

    Grew 36% QoQ, from 11 to 15 employees.

Sonomind Filings

Explore SEC and related filing metadata, where available.

Sonomind filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Sonomind's valuation, stock price, and market status.

Is Sonomind a public or private company?

Sonomind is a private company.

What is the current stock price of Sonomind?

Sonomind is a private company with no public stock price. No recent secondary market data is available.

How much is Sonomind worth (valuation)?

Valuation information for Sonomind is not publicly available.

Can I buy Sonomind stock?

Sonomind shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Sonomind's last funding round?

Sonomind's most recent funding round was Series A on May 13, 2026.

Who are the main investors in Sonomind?

Key investors in Sonomind include Critical Path Ventures, Bpifrance.

Will Sonomind IPO soon?

No public IPO plans have been announced for Sonomind.

How can I track Sonomind secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Sonomind's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParis
Employee Range13
Year Founded2024
Last FundingMay 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?